Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Vemurafenib × Clear all

Phase

Status

Completed 54 Terminated 22 Recruiting 14 Active not recruiting 13 Unknown 10 Withdrawn 7 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cisplatin 111 Carboplatin 109 Oxaliplatin 96 Drug Therapy 96 Capecitabine 87 Bevacizumab 86 Paclitaxel 81 pembrolizumab 77 Radiotherapy 77 Gemcitabine 77 Cyclophosphamide 76 tislelizumab 73 Specimen Handling 62 Fluorouracil 58 toripalimab 57 Injections 52 sintilimab 51 Docetaxel 49 Magnetic Resonance Spectroscopy 48 130-nm albumin-bound paclitaxel 45 Surgical Procedures, Operative 42 Leucovorin 41 Biopsy 41 fludarabine 38 Pemetrexed 38 anlotinib 37 Radiosurgery 37 Standard of Care 36 lenvatinib 35 Irinotecan 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06692491 2024-11-18

SPRING

Peking University Shenzhen Hospital

Phase 2 Not yet recruiting

Rare Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡